ANTX
#3591
AN2 Therapeutics, Inc. - Common Stock
5.5 8 USD
-0.03%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-2.79%
Monthly Change
+10.93%
6 month change
+407.27%
Year Change
+398.21%
Previous Close
5.7 4
Open
5.5 8
Low
5.5 8
High
5.5 8
Volume
15
Financials
- Market Capitalization 210.57 M
- Employee 21
- Founded 2017
- CEO N/A
- Website www.an2therapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00QYLYBK4
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 3588 |  ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.92 USD | -3.63% | -7.89% | +37.74% | +116.30% | 211.17 M USD | ||
| 3589 |  CRBP Corbus Pharmaceuticals Holdings, Inc. - Common Stock | 10.91 USD | -1.98% | +6.96% | +22.58% | -34.28% | 211.01 M USD | ||
| 3592 |  IMUX Immunic, Inc. - Common Stock | 15.40 USD | -5.52% | -6.55% | +18.46% | +1778.05% | 210.12 M USD | ||
| 3594 |  ORMP Oramed Pharmaceuticals Inc. - Common Stock | 5.03 USD | -1.37% | +4.57% | +25.75% | +135.05% | 209.23 M USD |
Frequently asked questions about AN2 Therapeutics, Inc. Common Stock
What is the AN2 Therapeutics, Inc. Common Stock stock price today?
The current price of AN2 Therapeutics, Inc. Common Stock (ANTX) is 5.58. Over the past 24 hours, the stock has changed by -2.79%. Follow the ANTX chart for real-time price dynamics.
What is the stock ticker of AN2 Therapeutics, Inc. Common Stock?
AN2 Therapeutics, Inc. Common Stock trades under the ticker ANTX. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is AN2 Therapeutics, Inc. Common Stock stock going up?
ANTX has changed by -4.12% over the last week, +10.93% over the last month, and +398.21% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of AN2 Therapeutics, Inc. Common Stock?
AN2 Therapeutics, Inc. Common Stock currently has a market capitalization of 210.57 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
Does AN2 Therapeutics, Inc. Common Stock release financial reports?
Yes. You can track AN2 Therapeutics, Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What were AN2 Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, AN2 Therapeutics, Inc. Common Stock reported earnings of -0.18 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was AN2 Therapeutics, Inc. Common Stock net income for the last quarter?
AN2 Therapeutics, Inc. Common Stock reported net income of -8.19 M for the last quarter. The previous quarter showed -10.03 M, which means net income changed by +18.38%.
How many employees does AN2 Therapeutics, Inc. Common Stock have?
As of the latest available data, AN2 Therapeutics, Inc. Common Stock has 21 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy AN2 Therapeutics, Inc. Common Stock stock?
You can buy AN2 Therapeutics, Inc. Common Stock (ANTX) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in AN2 Therapeutics, Inc. Common Stock stock?
Investing in AN2 Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ANTX chart and related analysis on metatrader.com as part of your research.